Some images has been designed using resources from Unsplash & Pixabay & Pexels & Freepik and some icons from Flaticon
跳到主要內容
Search
:::

鄭浩民 (Hao-Min Cheng)

鄭浩民(Hao-Min Cheng)圖 Appointment

[Profile]

  • Education
    • Doctor of Philosophy of Medicine, The University of Adelaide, Australia with full scholarship support (International Postgraduate Research Scholarship); Certificate No. 4887863E,
    • Medical doctor; National Yang-Ming University, Taipei, Taiwan, R.O.C.,
  • Career and Experience
    Current Positions：
    • - Now, Director, Center for Evidence-based Medicine, Taipei Veterans General Hospital,
    • - Now, Attending Physician, Department of Critical Care Medicine, Taipei Veterans General Hospital, Taipei, R.O.C.
    • - Now, Attending Physician, Division of cardiology, Taipei Veterans General Hospital,
    • - Now, Associate Professor in Faculty of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan,
    • - Now, Joint Appointed Assistant Professor in Institute of Public Health, National Yang Ming Chiao Tung University, Taipei, Taiwan,
    Experiences：
    • - , Director, Center for Evidence-based Medicine, Taipei Veterans General Hospital (2017.7 ~),
    • - , Research Fellow of Cardiology, Veterans General Hospital, Taipei, Taiwan (2006-2007),
    • - , Chief Resident of Internal Medicine, Veterans General Hospital, Taipei, Taiwan (2005-2006),
    • - , Chief Resident of Cardiology, Veterans General Hospital, Taipei, Taiwan (2003-2005),
    • - , Resident of Internal Medicine, Veterans General Hospital, Taipei, Taiwan (2000-2003),
  • Medical Expertise
    1. Hypertension
    2. Congestive heart failure
    3. Echocardiography
    4. Coronary heart disease
    5. Management of coronary heart disease
    6. Percutaneous coronary intervention
    7. Hyperlipidemia

[Publications]

  1. *Huang CJ, *Wang WT, Sung SH, Chen CH, Gregory YH Lip, Cheng HM,** Chiang CE.** Blood Glucose Reduction by Diabetic Drugs with Minimal Hypoglycemia Risk for Cardiovascular Outcomes: Evidence from Meta-regression Analysis of Randomized Controlled Trials. Diabetes, Obesity and Metabolism. 2018; 20(9):2131-2139.
  2. Huang JT, ** Cheng HM, Yu WC, Lin YP, Sung SH, Chen CH**,  Increased Nighttime Pulse Pressure Variability but Not Ambulatory Blood Pressure Levels Predicts 14-Year All-Cause Mortality in Patients on Hemodialysis. Hypertension. 2019; 74(3):660-668.
  3. Hung CS, Sung SH, Liao CW, Wu VC,  Chen CH, Cheng HM**,  Lin YH**. TAIPAI Study Group. Aldosterone Induces Vascular Damage：A Wave Reflection Analysis Study. Hypertension. 2019; 74:623-629.
  4. Chuang SY,  Wang PN, Chen LK,  Chou K, Chung CP,  Chen CH, Gary F. Mitchell, Pan WH, ** Cheng HM. Associations of Blood Pressure and Carotid Flow Velocity with Brain Volume and Cerebral Small Vessel Disease in a Community-based Population. Translational stroke research. 2021; 12(2):248-258
  5. *Huang CJ, * Wang WT,  Sung SH, Chen CH,  Gregory Y. H. Lip,**Cheng HM, ** Chiang CE. Revisiting “Intensive” Blood Glucose Control: A Causal Directed Acyclic Graph-guided Systematic Review of Randomized Controlled Trials. Diabetes, Obesity and Metabolism. 2022; in press

限於篇幅,以上謹為代表著作

回到最上